Brief: India's Glenmark Life Sciences CEO Says Process Of Selling A Part Of Glenmark Pharmaceuticals Stake In Glenmark Lifesciences Is On
July 21 (Reuters) - Glenmark Life Sciences Ltd
GLEM.NS :
* PROCESS OF SELLING A PART OF GLENMARK PHARMACEUTICALS
STAKE IN
GLENMARK LIFESCIENCES IS ON
* GLENMARK PHARMACEUTICALS IS RUNNING THE SALE PROCESS
* WE’RE CONTRIBUTING TO THE SALE PROCESS, WHEREEVER REQUIRED
* GLENMARK PHARMACEUTICALS IS RUNNING THE SALE PROCESS
Source text for Eikon: ID:
Further company coverage: GLEM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alivus Life Sciences
See all newsBrief: Alivus Life Sciences Incorporates Subsidiary Alivus Life Sciences Do Brasil Ltda In Brazil
Brief: Alivus Life Sciences To Buy 76% Stake In Iqgen-X Pharma For Approx 91.2 Million Rupees
India's Alivus rises to 15-month high as brokerages optimistic about drugmaker's annual outlook
India's Alivus Life Sciences rises after quarterly profit increase
Brief: Alivus Life Sciences Ltd March-Quarter Profit 1.63 Billion Rupees